Cummings School of Veterinary Medicine at Tufts University
No Photo Available

Assistant Professor

Campus Phone:
508-887-4756

Education

  • PhD - Albert Einstein College of Medicine - 1992 
  • MS - Albert Einstein College of Medicine - 1991
  • BA - Hamline University - 1989

Board Certification

  • Diplomate of the American College of Veterinary Microbiologists (DACVM)
  1. Mukherjee, J., C. McCann, K. Baldwin, K. Ofori, C. Taylor, J. Hill, C. Shoemaker, P. Harrison and S. Tzipori.  2012.  “Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1.”  Toxins  4(12):1565-1581.

     

  2. Mukherjee, J., J.M. Tremblay, C.E. Leysath, K. Ofori, K. Baldwin, X. Feng, D. Bedenice, S. Tzipori, and C.B. Shoemaker.  2011.  A Novel Strategy for Development or Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model.”  Plos One 7:1-7e29941.

  3. Sepulveda, J., J. Mukherjee, S. Tzipori, L. Simpson, C. Shoemaker.  2010.  “Efficient serum clearance of botulinum neurotoxin using a pool of small antitoxin binding agents." Infection and Immunity  78(2):756-763.

  4. Mukherjee, J., K. Chios, D. Fishwild, D. Hudson, S. O’Donnell, S. Rich, A. Donohue-Rolfe, and S. Tzipori.  2002.  “Production and Characterization of Protective Human Antibodies Against Shiga-Toxin 1 (Stx1).”  Infection and Immunity 70(10):5896-5899.

  5. Mukherjee, J., K. Chios, D. Fishwild, D. Hudson, S. O’Donnell, S. Rich, A. Donohue-Rolfe, and S. Tzipori.  2002.  “Human Stx2 Antibodies Prevent Systemic Complications ofEscherichia coli 0157:H7 Infection.”  Infection and Immunity  70(2):612-619.

  6. Mukherjee, J., M.D. Scharff, and A. Casadevall.  1995.  "Monoclonal Antibodies toCryptococcus neoformans Glucuronoxylomannan Enhance Fluconazole Efficacy." Antimicrobial Agents and Chemotherapy  39:1398-1405.

  7. Mukherjee, J., M.D. Scharff, and A. Casadevall.  1995.  "Variable Efficacy of Passive Antibody Administration Against Diverse Cryptococcus neoformans Strains."  Infection and Immunity  63:3353-3359.

  8. Mukherjee, J., G. Nussbaum, M.D. Scharff, and A. Casadevall.  1995.  "Somatic Mutation Can Generate Differences in Specificity that Change the Protective Efficacy of Antibodies toCryptococcus neoformans."  Journal of Experimental Medicine  181:405-409.

  9. Mukherjee, J., L.S. Zuckier, M.D. Scharff, and A. Casadevall.  1994.  "Therapeutic Efficacy of Monoclonal Antibodies to Cryptococcus neoformans Glucuronoxylomannan Alone and in Combination with Amphotericin B."  Antimicrobial Agents and Chemotherapy  38:580-587.

  10. Mukherjee, J., L.-A. Pirofski, M.D. Scharff, and A. Casadevall.  1993.  "Antibody-Mediated Protection in Mice with Lethal Intracerebral Cryptococcus neoformans Infection." Proceedings of the National Academy of Science (PNAS)  90:3636-3640.

  11. Mukherjee, J., A. Casadevall, and M.D. Scharff.  1993.  "Molecular Characterization of the Humoral  Responses to Cryptococcus neoformans Infection and Glucuronoxylomannan-Tetanus Toxoid Conjugate  Immunization."  Journal of Experimental Medicine  177:1105-1116.

General Research Interests

Development of immune-based methods for diagnosis, therapy, and prevention of infectious and toxin-mediated diseases of human, veterinary and/or zoonotic concern; animal model development; in vivo evaluation of candidate therapeutics; veterinary microbiology and parasitology.

Research Interests by Area

Infectious Diseases: Prevention and Control
  • Botulism antidotes and anti-toxins

Laboratory Personnel

  • Karen Baldwin, Animal Specialist
  • Courtney Boucher, Research Technician
  • Kwasi Ofori, Research Assistant